Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (200)

« Back to Publications

Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.

West CE. et al, (2023), Sci Data, 10

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.

Sarangarajan R. et al, (2021), J Racial Ethn Health Disparities, 8, 973 - 980

Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).

Grozinsky-Glasberg S. et al, (2020), Endocr Relat Cancer, 27, R345 - R355

Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells

LINES K. et al, (2020), Endocrine-Related Cancer

A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function

Fagan V. et al, (2019), Journal of Medicinal Chemistry

Organizational Innovation for Developing New Medicines That Target Aging and Age-Related Conditions

(2019), journals of gerontology. Series A

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.

Wu X. et al, (2019), Prostate, 79, 1079 - 1089

A genetics-led approach defines the drug target landscape of 30 immune-related traits

Fang H. et al, (2019), Nature Genetics

ANGIOTENSIN 2 TYPE 2 RECEPTOR BLOCKADE IS A NOVEL TARGET FOR MURINE OSTEOARTHRITIS PAIN

von Loga IS. et al, (2019), OSTEOARTHRITIS AND CARTILAGE, 27, S420 - S421

Design, synthesis and characterization of covalent KDM5 inhibitors

(2019), Angewandte Chemie

An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.

D'Ascenzio M. et al, (2019), Angewandte Chemie (International ed. in English), 58, 1007 - 1012

Open innovation in neuroscience research and drug discovery

Hunter AJ. et al, (2018), Brain and Neuroscience Advances, 2, 239821281879927 - 239821281879927

Donated Chemical Probes For Open Science

Marsden BD. et al, (2018), eLife

Therapeutics discovery: From bench to first in-human trials

Al-Hujaily EM. et al, (2018), Biomedical Reports, 8, 275 - 282

BROMODOMAIN INHIBITORS ARE POTENT EPIGENETIC REGULATORS OF CATABOLIC GENE EXPRESSION IN HUMAN OSTEOARTHRITIC CHONDROCYTES

de Andres MC. et al, (2018), OSTEOARTHRITIS AND CARTILAGE, 26, S154 - S154

Load More

1
2
3
4
5
6
7
...
»